Patients with Pancreatic Cancer with a History of Short- and Long-Term Diabetes

Background/Objectives: The relationship between pancreatic cancer (PC) and diabetes mellitus (DM) is complex. The aim was to investigate the prevalence of DM in patients with PC diagnosed within two years of the PC diagnosis (NODM) and in patients diagnosed more than two years previously (LSDM), and to determine the clinical profile and prognosis of these patients. Methods: A retrospective case–control study of patients diagnosed with PC drawn from the Lleida Population-Based Cancer Registry (Spain). Data were collected from the electronic health records. The cases were patients with PC who had a history of diabetes of ≤2 years (NODM) or >2 years (LSDM), and the controls were patients with PC who did not have diabetes. The factors associated with NODM and LSDM were determined using adjusted odds ratios (aOR) via logistic regression models. Results: A total of 574 patients with PC were studied; 40.2% were diabetic (cases) and 59.8% were non-diabetic (controls). Of the cases, 24.7% had NODM and 75.3% had LSDM. The group with NODM was associated with the 65–74 age group (OR 3.09; 95% CI 1.47–6.49) and had higher levels of transaminase abnormalities (p < 0.001) and hypertension (OR 13.50; 95% CI 3.33–54.8). The group with LSDM was associated with being aged 74 years or older (aOR 2.38; 95% CI 1.44–3.91), being overweight (aOR 1.96; 95% CI 1.15–3.35) and having coronary heart disease (aOR 2.17; 95% CI 1.29–3.66). The mean survival time was shorter in the LSDM group (315 days) than in the NODM group (433 days) (p < 0.017). Conclusions: Co-diagnosis of PC and DM is common. DM and its comorbidities exhibit different characteristics depending on the time of diagnosis, prior to the onset of PC. These differences may help to identify patients who could benefit from monitoring strategies.

Authors

Institutions

Publication Details

Journal
Diabetology
Published
2026-11-20
DOI
https://doi.org/10.3390/diabetology7110226
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Patients with Pancreatic Cancer with a History of Short- and Long-Term Diabetes

Jordi Mateo, Francesc Solsona, Pere Godoy, Josep Montserrat-Capdevila et al.
1 links
Diabetology
Pancreatic and Hepatic Oncology Research
article

Patients with Pancreatic Cancer with a History of Short- and Long-Term Diabetes

Jordi Mateo, Francesc Solsona, Pere Godoy, Josep Montserrat-Capdevila, Araceli Fuentes, Leonardo Galván, Isaac Torres Espuña, Dídac Florensa
article en

Abstract

Background/Objectives: The relationship between pancreatic cancer (PC) and diabetes mellitus (DM) is complex. The aim was to investigate the prevalence of DM in patients with PC diagnosed within two years of the PC diagnosis (NODM) and in patients diagnosed more than two years previously (LSDM), and to determine the clinical profile and prognosis of these patients. Methods: A retrospective case–control study of patients diagnosed with PC drawn from the Lleida Population-Based Cancer Registry (Spain). Data were collected from the electronic health records. The cases were patients with PC who had a history of diabetes of ≤2 years (NODM) or >2 years (LSDM), and the controls were patients with PC who did not have diabetes. The factors associated with NODM and LSDM were determined using adjusted odds ratios (aOR) via logistic regression models. Results: A total of 574 patients with PC were studied; 40.2% were diabetic (cases) and 59.8% were non-diabetic (controls). Of the cases, 24.7% had NODM and 75.3% had LSDM. The group with NODM was associated with the 65–74 age group (OR 3.09; 95% CI 1.47–6.49) and had higher levels of transaminase abnormalities (p < 0.001) and hypertension (OR 13.50; 95% CI 3.33–54.8). The group with LSDM was associated with being aged 74 years or older (aOR 2.38; 95% CI 1.44–3.91), being overweight (aOR 1.96; 95% CI 1.15–3.35) and having coronary heart disease (aOR 2.17; 95% CI 1.29–3.66). The mean survival time was shorter in the LSDM group (315 days) than in the NODM group (433 days) (p < 0.017). Conclusions: Co-diagnosis of PC and DM is common. DM and its comorbidities exhibit different characteristics depending on the time of diagnosis, prior to the onset of PC. These differences may help to identify patients who could benefit from monitoring strategies.

DiabetologyVol. 7(11)
Universitat de Lleida (ES), Hospital Universitari de Santa Maria (ES), Instituto de Investigación Biomédica de Lleida (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon